TipRanks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
INTS
Intensity Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see INTS full AI Analyst Report?

Intensity Therapeutics, Inc. (INTS) Stock News & Sentiment

250 Followers
Intensity Therapeutics Earnings Call Highlights Promise and Strain
Premium
Company Announcements
Intensity Therapeutics Earnings Call Highlights Promise and Strain
2M ago
INTS
INTS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INTS Upcoming Earnings Report: What to Expect?
3M ago
INTS
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
Premium
Company Announcements
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
4M ago
8K
INTS
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
Premium
Company Announcements
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
7M ago
INTS
Intensity Therapeutics Expands ATM Equity Offering Capacity
Premium
Company Announcements
Intensity Therapeutics Expands ATM Equity Offering Capacity
7M ago
8K
INTS
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
8M ago
INTS
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
Premium
Company Announcements
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
8M ago
8K
INTS
More INTS News >

INTS News on the Web

Intensity Therapeutics price target lowered to $15 from $30 at Alliance Global
TipRanks News
Bearish
INTS Upcoming Earnings Report: What to Expect?
TipRanks News
Neutral
Cue Biopharma Appoints Ahlers As CFO Following IND Filing And Pipeline Progress
rttnews
Neutral
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
TipRanks News
Neutral
Intensity Therapeutics Wins 2026 Award for Cancer Treatment Innovation—What Does This Mean for Patients and Investors?
Market Chameleon
Neutral
Intensity Therapeutics, Inc. (INTS) Receives a Buy from Alliance Global Partners
TipRanks News
Neutral
Intensity Therapeutics reports Q1 EPS (96c), consensus ($1.09)
TipRanks News
Bullish
Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
INTS
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INTS’s Media Buzz Sentiment?
Currently, no data Available
What is INTS’s weekly average amount of articles?
Currently, no data Available
What is INTS’s News Sentiment?
100% of articles about INTS were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    LHLabcorp Holdings
    HELPHelus Pharma
    GMABGenmab
    KZIAKazia Therapeutics
    IQVIQVIA Holdings
    Showing the stocks with the most bullish news sentiment over the past week